Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

1.0K
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
1.0K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

1.3K
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.3K
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

548
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
548
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

486
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
486
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

891
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
891
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

747
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Operational performance of the 2023 World Heart Federation screening criteria for rheumatic heart disease in a high-risk, resource-limited population.

Open heart·2026
Same author

AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure (2026).

Global heart·2026
Same author

AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure (2026).

European heart journal·2026
Same author

AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure (2026).

Circulation·2026
Same author

Co-Developing Strategies for Patient Engagement in Decentralized Rheumatic Heart Disease Care: Lessons from Northern Uganda.

Global heart·2026
Same author

AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure (2026).

Journal of the American College of Cardiology·2026

相关实验视频

Updated: May 5, 2026

Promoter Capture Hi-C: High-resolution, Genome-wide Profiling of Promoter Interactions
10:16

Promoter Capture Hi-C: High-resolution, Genome-wide Profiling of Promoter Interactions

Published on: June 28, 2018

33.1K

美国心脏协会呼吁采取行动,减少风湿性心脏病的全球负担:美国心脏协会的政策声明

Andrea Beaton, Flavia B Kamalembo, James Dale

    Circulation
    |October 19, 2020
    PubMed
    概括

    风湿性心脏病 (RHD) 影响全球数以百万计的人. 美国心脏协会致力于通过教育,资源,研究和宣传来预防和照顾RHD.

    更多相关视频

    Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay
    13:51

    Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay

    Published on: November 11, 2018

    10.2K
    Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
    08:15

    Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

    Published on: January 31, 2020

    8.9K

    相关实验视频

    Last Updated: May 5, 2026

    Promoter Capture Hi-C: High-resolution, Genome-wide Profiling of Promoter Interactions
    10:16

    Promoter Capture Hi-C: High-resolution, Genome-wide Profiling of Promoter Interactions

    Published on: June 28, 2018

    33.1K
    Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay
    13:51

    Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay

    Published on: November 11, 2018

    10.2K
    Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
    08:15

    Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

    Published on: January 31, 2020

    8.9K

    科学领域:

    • 心血管医学
    • 全球健康
    • 公共卫生政策

    背景情况:

    • 风湿性心脏病 (RHD) 是一个严重的全球健康负担,每年约有4000万人受其影响,造成近30万人死亡.
    • 2018年世界卫生大会的一项决议规定了全球协调应对RHD的任务.
    • 美国心脏协会 (AHA) 旨在领导和支持RHD护理和预防的国际努力.

    研究的目的:

    • 概述美国心脏协会对抗风湿性心脏病的承诺.
    • 详细介绍AHA全球RHD控制战略的重点领域.
    • 鼓励在RHD预防和管理方面的协作努力.

    主要方法:

    • AHA承诺在五个关键领域提供支持:医疗保健工作者教育,基于证据的预防策略的实施,获得基本医疗资源,研究倡议以及提高全球意识和能力的倡导.
    • 这一承诺是在世界卫生大会授权的全球RHD应对框架内进行的.

    主要成果:

    • AHA的战略承诺涉及RHD控制的多方面,从专业培训到政策宣传.
    • 这一计划旨在加强现有努力, 激发对抗RHD的广泛参与.

    结论:

    • 美国心脏协会致力于领导和支持全球的风湿性心脏病预防和护理计划.
    • AHA的综合战略包括教育,资源,研究和宣传,旨在激发全球减少RHD负担的协作行动.